Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bright

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Chest Surgery Clinics of North America|March 20, 2001
Novel molecular and immunotherapeutic strategies for lung cancerH I Pass, G Kalemkerian, R K Bright
International Reviews of Immunology|September 10, 2003
Tumor-associated antigens: from discovery to immunityJennifer D Lewis, Brian D Reilly, Robert K Bright
Scandinavian Journal of Immunology|October 1, 1994
Molecular characterization of immunoglobulin variable regions from murine monoclonal antibodies specific for simian virus 40 large tumour antigenM H Shearer, R K Bright, R C Kennedy
Human Vaccines & Immunotherapeutics|September 7, 2022
Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotypeC Riccay Elizondo, Jennifer D Bright, Robert K Bright
Biotechnology (Reading, Mass.)|January 1, 1992
Active immunization strategies using anti-idiotypic antibodiesR L Mernaugh, R K Bright, R C Kennedy
Analytical Chemistry|August 31, 2013
Photolithographic fabrication of microapertures with well-defined, three-dimensional geometries for suspended lipid membrane studiesChristopher A Baker, Leonard K Bright, Craig A Aspinwall
Clinical and Experimental Immunology|June 1, 1994
Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopesR K Bright, M H Shearer, R C Kennedy
Cancer Research|December 1, 1993
Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotypeM H Shearer, R K Bright, R C Kennedy
Cancer Immunology, Immunotherapy : CII|March 1, 1995
Examination of lymphokines induced in mice following immunization with recombinant simian virus 40 large tumor antigenR K Bright, M H Shearer, R C Kennedy
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Comparison of the murine humoral immune response to recombinant simian virus 40 large tumor antigen: epitope specificity and idiotype expressionR K Bright, M H Shearer, R C Kennedy
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Chest Surgery Clinics of North America|March 20, 2001
Novel molecular and immunotherapeutic strategies for lung cancerH I Pass, G Kalemkerian, R K Bright
International Reviews of Immunology|September 10, 2003
Tumor-associated antigens: from discovery to immunityJennifer D Lewis, Brian D Reilly, Robert K Bright
Scandinavian Journal of Immunology|October 1, 1994
Molecular characterization of immunoglobulin variable regions from murine monoclonal antibodies specific for simian virus 40 large tumour antigenM H Shearer, R K Bright, R C Kennedy
Human Vaccines & Immunotherapeutics|September 7, 2022
Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotypeC Riccay Elizondo, Jennifer D Bright, Robert K Bright
Biotechnology (Reading, Mass.)|January 1, 1992
Active immunization strategies using anti-idiotypic antibodiesR L Mernaugh, R K Bright, R C Kennedy
Analytical Chemistry|August 31, 2013
Photolithographic fabrication of microapertures with well-defined, three-dimensional geometries for suspended lipid membrane studiesChristopher A Baker, Leonard K Bright, Craig A Aspinwall
Clinical and Experimental Immunology|June 1, 1994
Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopesR K Bright, M H Shearer, R C Kennedy
Cancer Research|December 1, 1993
Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotypeM H Shearer, R K Bright, R C Kennedy
Cancer Immunology, Immunotherapy : CII|March 1, 1995
Examination of lymphokines induced in mice following immunization with recombinant simian virus 40 large tumor antigenR K Bright, M H Shearer, R C Kennedy
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Comparison of the murine humoral immune response to recombinant simian virus 40 large tumor antigen: epitope specificity and idiotype expressionR K Bright, M H Shearer, R C Kennedy
Pageof 11